Oral upadacitinib combined with 308-nm excimer light for refractory progressive vitiligo in children and adults：A prospective observational study

Published: 17 December 2024| Version 1 | DOI: 10.17632/966bgbnxfj.1
Contributors:
wenyan lau,
, Xibao Zhang

Description

Figure 2. Representative clinical photos of refractory vitiligo patients at the baseline and 12-week follow-up. Patient 2 before (A) and after (B) treatment. Patient 13 before (C) and after (D) treatment. Patient 14 before (E) and after (F) treatment. Table 2: Follow-up to 16 weeks (n = 8), 20 weeks (n = 5), and 24 weeks (n = 3) treatment outcomes of the patients.

Files

Institutions

Guangzhou Medical University

Categories

Vitiligo

Licence